Sievert W - Search Results

1

Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.

Lok AS, Trinh H, Carosi G, Akarca US, Gadano A, Habersetzer F, Sievert W, Wong D, Lovegren M, Cohen D, Llamoso C. Lok AS, et al. Among authors: sievert w. Gastroenterology. 2012 Sep;143(3):619-628.e1. doi: 10.1053/j.gastro.2012.05.037. Epub 2012 May 27. Gastroenterology. 2012. PMID: 22643350 Clinical Trial.

2

Management issues in chronic viral hepatitis: hepatitis C.

Sievert W. Sievert W. J Gastroenterol Hepatol. 2002 Apr;17(4):415-22. doi: 10.1046/j.1440-1746.2002.02725.x. J Gastroenterol Hepatol. 2002. PMID: 11982722 Review.

3

Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.

Sievert W, Pianko S, Warner S, Bowden S, Simpson I, Bowden D, Locarnini S. Sievert W, et al. Am J Gastroenterol. 2002 Apr;97(4):982-7. doi: 10.1111/j.1572-0241.2002.05550.x. Am J Gastroenterol. 2002. PMID: 12003436

4

Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.

Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White P, French R, Rawlinson W, Lloyd AR, Kaldor JM; Australian Trial In Acute Hepatitis C Study Group. Dore GJ, et al. Gastroenterology. 2010 Jan;138(1):123-35.e1-2. doi: 10.1053/j.gastro.2009.09.019. Epub 2009 Sep 24. Gastroenterology. 2010. PMID: 19782085 Free PMC article.

5

Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: a multicenter clinical experience.

Ratnam D, Dev A, Nguyen T, Sundararajan V, Harley H, Cheng W, Lee A, Rusli F, Chen R, Bell S, Pianko S, Sievert W. Ratnam D, et al. Among authors: sievert w. J Gastroenterol Hepatol. 2012 Sep;27(9):1447-53. doi: 10.1111/j.1440-1746.2011.07051.x. J Gastroenterol Hepatol. 2012. PMID: 22168789

6

Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis.

Prijatmoko D, Strauss BJ, Lambert JR, Sievert W, Stroud DB, Wahlqvist ML, Katz B, Colman J, Jones P, Korman MG. Prijatmoko D, et al. Among authors: sievert w. Gastroenterology. 1993 Dec;105(6):1839-45. doi: 10.1016/0016-5085(93)91083-t. Gastroenterology. 1993. PMID: 8253360

7

Southeast Asian patients with chronic hepatitis C: the impact of novel genotypes and race on treatment outcome.

Dev AT, McCaw R, Sundararajan V, Bowden S, Sievert W. Dev AT, et al. Among authors: sievert w. Hepatology. 2002 Nov;36(5):1259-65. doi: 10.1053/jhep.2002.36781. Hepatology. 2002. PMID: 12395338

8

Antiviral therapy for chronic hepatitis C.

Sievert W. Sievert W. Aust Fam Physician. 2003 Oct;32(10):826-32. Aust Fam Physician. 2003. PMID: 14596080 No abstract available.

9

The direct cost of managing patients with chronic hepatitis B infection in Australia.

Butler JR, Pianko S, Korda RJ, Nguyen S, Gow PJ, Roberts SK, Strasser SI, Sievert W. Butler JR, et al. Among authors: sievert w. J Clin Gastroenterol. 2004 Nov-Dec;38(10 Suppl 3):S187-92. doi: 10.1097/00004836-200411003-00012. J Clin Gastroenterol. 2004. PMID: 15602169

10

Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.

Roberts SK, Weltman MD, Crawford DH, McCaughan GW, Sievert W, Cheng WS, Rawlinson W, Desmond PV, Marks PS, Yoshihara M, Rizkalla B, Depamphilis JK, Dore GJ; Chariot Study Group. Roberts SK, et al. Among authors: sievert w. Hepatology. 2009 Oct;50(4):1045-55. doi: 10.1002/hep.23130. Hepatology. 2009. PMID: 19676125 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters